Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 1 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Phosphodiesterase type 5 inhibitors enhance chemotherapy in preclinical models of esophageal adenocarcinoma by targeting cancer-associated fibroblasts.
Cell Rep Med. 2022 Jun 21;3(6):100541. doi: 10.1016/j.xcrm.2022.100541.
Cell Rep Med. 2022.
PMID: 35732148
Free PMC article.
Genomic Analysis of Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma.
Izadi F, Sharpe BP, Breininger SP, Secrier M, Gibson J, Walker RC, Rahman S, Devonshire G, Lloyd MA, Walters ZS, Fitzgerald RC, Rose-Zerilli MJJ, Underwood TJ, On Behalf Of Occams.
Izadi F, et al. Among authors: sharpe bp.
Cancers (Basel). 2021 Jul 6;13(14):3394. doi: 10.3390/cancers13143394.
Cancers (Basel). 2021.
PMID: 34298611
Free PMC article.
Item in Clipboard
Residual cancer cells after apparent complete pathological response to neoadjuvant therapy in oesophageal adenocarcinoma.
Walker RC, Harrington J, Breininger SP, Pickering O, Hill SL, Sharpe BP, Grace B, Reddin I, Rajak R, Manousopoulou A, Garbis SD, Walters ZS, Rose-Zerilli MJJ, Underwood TJ.
Walker RC, et al. Among authors: sharpe bp.
Br J Surg. 2024 Apr 3;111(4):znae103. doi: 10.1093/bjs/znae103.
Br J Surg. 2024.
PMID: 38630793
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite